Viewing data from:

SCOPOLAMINE

ANDA

SCOPOLAMINE | A215329 | RHODES PHARMACEUTICALS LP

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TRANSDERM SCOP(TE code: AB)

API Supply Chain6 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

PHYTEX AUSTRALIA PARTY LTDSCOPOLAMINE BASE

DMF 74081988

PHYTEX AUSTRALIA PVT LTDSCOPOLAMINE HYDROBROMIDE

DMF 74151988

PHYTEX AUSTRALIA PARTY LTDSCOPOLAMINE METHONITRATE

DMF 74171988

FINE CHEMICALS CORP PTY LTDSCOPOLAMINE (HYOSCINE)

DMF 253162011

ALCHEM INTERNATIONAL PRIVATE LTDSCOPOLAMINE HYDROBROMIDE USP

DMF 307212016

ALKALOIDS CORPSCOPOLAMINE HYDROBROMIDE

DMF 317082017

BOEHRINGER INGELHEIM PHARMA KGInactiveSCOPOLAMINE AMINOXIDE HYDROBROMIDE

DMF 36221979

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveSCOPOLAMINE HYDROBROMIDE

DMF 61521983

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveSCOPOLAMINE

DMF 87231990

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveSCOPOLAMINE (HYOSCINE)

DMF 197742006

VITAL LABORATORIES PVT LTDInactiveSCOPOLAMINE BUTYL BROMIDE (HYOSCINE BUTYL BROMIDE)

DMF 244772010

VITAL LABORATORIES PVT LTDInactiveSCOPOLAMINE HYDRO BROMIDE USP

DMF 256132011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG/72HR

0 patents0 exclusivities▴

SYSTEM;TRANSDERMAL | Approved: May 6, 2024

No patent or exclusivity listings for this strength.